MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-29-0021603
Maks Pharmaceuticals Private Limited
Maks Pharmaceuticals Private Limited - chemicals in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹19.7 Lakh
▼ 30% YoY
Net profit · FY 2025
₹37,070
Net margin 1.9%
EBITDA · FY 2025
₹1.07 Lakh
EBITDA margin 5.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
28 yrs
Est. 1998
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered
About Maks Pharmaceuticals Private Limited
Data last updated:
Maks Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 21 April 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL1998PTC093355. Its GSTIN is 07AADCM3982D1ZI (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Anju Aggarwal and Madhusudan Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H – 47 Naveen Shahdara, New Delhi, Delhi, India – 110032.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.7 Lakh, a decline of 30% compared to the previous year. For the same year it recorded a net profit of ₹37,070 (net margin 1.9%) and EBITDA of ₹1.07 Lakh (EBITDA margin 5.4%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 13% over five years.
Court records list 7 cases involving the company, including 3 filed by the company and 4 filed against it; 1 case is pending.
Maks Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0021603). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232DL1998PTC093355
Registration Number 093355
Incorporation Date 21 April 1998
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-29-0021603
Recognitions & Rankings of Maks Pharmaceuticals
Contact details
Maks Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH – 47 Naveen Shahdara, New Delhi, Delhi, India – 110032
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Maks Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Maks Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Maks Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Maks Pharmaceuticals Private Limited, buy the company report.
Financials of Maks Pharmaceuticals Private Limited
FY 2025 filings availableMaks Pharmaceuticals Private Limited reported revenue of ₹19.7 Lakh (down 30% YoY) for FY 2025.
Revenue · FY 2025
₹19.7 Lakh ▼ 30%
Net profit · FY 2025
₹37,070 margin 1.9%
EBITDA · FY 2025
₹1.07 Lakh margin 5.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 30%
3 years · compounded
▼ 10%
5 years · compounded
▼ 13%
EBITDA CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 51%
5 years · compounded
▼ 19%
Revenue has declined at a compounded annual rate (CAGR) of 13% over five years, including a 30% fall in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹37,070 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maks Pharmaceuticals Private Limited, buy the company report.
Board of directors of Maks Pharmaceuticals Private Limited
Maks Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anju Aggarwal | Director | 25 Dec 2000 | 25 Years 10 Months | Current |
| Madhusudan Agarwal | Director | 21 Apr 1998 | 28 Years 6 Months | Current |
Auditor
Maks Pharmaceuticals Private Limited is audited by J B GOEL & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J B GOEL & ASSOCIATES | FY 2017 | 087522 |
Shareholding
The shareholding of Maks Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Maks Pharmaceuticals Private Limited, buy the company report.
Legal cases
Maks Pharmaceuticals Private Limited has 7 court cases on record: 3 filed by Maks Pharmaceuticals, 4 filed against it. 1 case is pending and 6 are disposed.
Total cases
7
Filed by the company
3
Filed against the company
4
Pending
1
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 4 | 1 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Shahdara, Delhi | Execution petition | Filed against the company by Ms Yamuna Chit Fund Pvt. Ltd. | Disposed |
| District court, Shahdara, Delhi | Court case (Civ Suit) | Filed against the company by Yamuna Chit Fund Pvt. Ltd. | Disposed |
| District court, Shahdara, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, North East, Delhi | Court case (RCA DJ) | Filed by the company against an individual | Disposed |
| District court, North East, Delhi | Court case (MCA DJ) | Filed by the company against an individual | Disposed |
To see the full case history of Maks Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maks Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Maks Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCM3982D1ZI | Delhi | Active | 01 Jul 2017 |
| 09AADCM3982D1ZE | Uttar Pradesh | Active | 03 Mar 2021 |
To see the full GST registrations and return filing status of Maks Pharmaceuticals Private Limited, buy the company report.
Recent activity
Maks Pharmaceuticals Private Limited has 4 board changes on record since 1998: 2 appointments and 2 cessations. The latest: Manu Agarwal ceased to be Director on 05 Jan 2012.
AGM
Maks Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Maks Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Manu Agarwal ceased to be Director.
Ceased
Sumit Agarwal ceased to be Director.
Appointed
Anju Aggarwal was appointed as Director.
Appointed
Madhusudan Agarwal was appointed as Director.
Incorporation
21 Apr 1998
Maks Pharmaceuticals Private Limited was registered on 21 Apr 1998 with Roc Delhi I & aged 28 years 6 months as per MCA records.
Frequently asked questions
Maks Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 21 April 1998 (28+ years old) and is registered under CIN U24232DL1998PTC093355.
Maks Pharmaceuticals has 2 current directors:
- Anju Aggarwal - Director
- Madhusudan Agarwal - Director
The latest financial statements of Maks Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Maks Pharmaceuticals is 07AADCM3982D1ZI, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AADCM3982D1ZE (Uttar Pradesh).
The CIN (Corporate Identification Number) of Maks Pharmaceuticals is U24232DL1998PTC093355. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maks Pharmaceuticals has 7 court cases on record: 3 filed by the company and 4 filed against it. 1 is pending.
Maks Pharmaceuticals was incorporated on 21 April 1998, making it 28+ years old. It is registered with the Registrar of Companies, Delhi.
Manu Agarwal ceased to be Director on 05 Jan 2012. Sumit Agarwal ceased to be Director on 05 Jan 2012. Anju Aggarwal was appointed as Director on 25 Dec 2000. Maks Pharmaceuticals has 4 board changes on record in total.
Yes, Maks Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-29-0021603).
The registered office of Maks Pharmaceuticals is at H – 47 Naveen Shahdara, New Delhi, Delhi, India – 110032.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages